↓ Skip to main content

ARID1A Mutation in Metastatic Breast Cancer: A Potential Therapeutic Target

Overview of attention for article published in Frontiers in oncology, November 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
ARID1A Mutation in Metastatic Breast Cancer: A Potential Therapeutic Target
Published in
Frontiers in oncology, November 2021
DOI 10.3389/fonc.2021.759577
Pubmed ID
Authors

Xuan Cheng, Jian-Xiong Zhao, Feng Dong, Xu-Chen Cao

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 8%
Researcher 3 8%
Student > Doctoral Student 2 5%
Student > Bachelor 2 5%
Student > Ph. D. Student 2 5%
Other 4 10%
Unknown 24 60%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 23%
Immunology and Microbiology 3 8%
Medicine and Dentistry 2 5%
Computer Science 1 3%
Unspecified 1 3%
Other 0 0%
Unknown 24 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 December 2021.
All research outputs
#15,665,425
of 26,503,275 outputs
Outputs from Frontiers in oncology
#4,439
of 23,231 outputs
Outputs of similar age
#206,776
of 450,228 outputs
Outputs of similar age from Frontiers in oncology
#230
of 1,481 outputs
Altmetric has tracked 26,503,275 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23,231 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,228 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 1,481 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.